Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Clasificación en acciones #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Precio por acción
$25.61
Última sincronización: 2025-10-10
Capitalización bursátil
$1.37B
Cambio (1 día)
0.20%
Cambio (1 año)
1.59%
País
US
Comercio Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Categoría

EPS de Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Harrow Health, Inc. 8.625% Senior Notes due 2026, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Harrow Health, Inc. 8.625% Senior Notes due 2026 desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras